p53 was found to control tumor immune cell crosstalk as the inhibition of p53 degradation by the MDM2 inhibitor HDM201 increased CD8+ T cells and the CD8/Treg (regulatory T cell) ratio, leading to an improved immune mediated anti-tumor response [151]. Here, CD8A is linked to neoplasm.